Change - Announcement of Appointment::Appointment of Director - Mr Quek Hong Sheng Roy

Issuer & Securities

Issuer/ Manager
ROWSLEY LTD.
Securities
ROWSLEY LTD. - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
25-Apr-2018 21:15:44
Status
New
Announcement Sub Title
Appointment of Director - Mr Quek Hong Sheng Roy
Announcement Reference
SG180425OTHROIOU
Submitted By (Co./ Ind. Name)
Hasan Malik
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr Quek Hong Sheng Roy as Executive Director and Chief Executive Officer, Healthcare

Additional Details

Date Of Appointment
25/04/2018
Name Of Person
Mr Quek Hong Sheng Roy
Age
49
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
With the transformation of the company and addition of healthcare as the core business arising from the acquisition of Sasteria Pte Ltd, the Board feels that Mr Quek's appointment is a natural fit and maintains continuity in the business. Mr Quek has been leading the leadership teams in Singapore and Malaysia as Executive Chairman of the Board of Directors of Thomson Medical since November 2015, and also executive director and group CEO of TMC Life Sciences Bhd since June 2015. He is eminently qualified, having served as Deputy Secretary in the Ministry of Health, and in various capacities in other Ministries, when he was a member of the Singapore Administrative Service.
Whether appointment is executive, and if so, the area of responsibility
Mr Quek will be appointed as Executive Director and Chief Executive Officer in charge of the core business, healthcare, continuing his current role in leading the healthcare business of Thomson Medical and TMC Life Sciences Berhad.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chief Executive Officer, Healthcare
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
Executive Chairman of Thomson Medical since 16 November 2015 and also an executive director and group Chief Executive Officer of TMC Life Sciences Bhd since 2 June 2015. Mr Quek was a member of the Singapore Administrative Service and had served as Deputy Secretary in the Ministry of Health and in various capacities in the Ministry of Defence, Ministry of Education, Ministry of Community Development, Youth and Sports, Ministry of Health, Ministry of Home Affairs and the Prime Minister's Office prior to joining the private sector.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Please see attached list
Present
Please see attached List
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of a listed company?
Yes
If Yes, Please provide details of prior experience
Executive Director and Group Chief Executive Officer of TMC Life Sciences Bhd since 2 June 2015

Attachments